Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Prognostic Impact of Germ-Line FCGR2A (H131R), FCGR3A (F158V), and FCGR2B (I232T) Single Nucleotide Polymorphisms in Lymphoma Patients Treated with Obinutuzumab or Rituximab in Combination with Chemotherapy: Results from the Phase III GALLIUM and GOYA Clinical Trials

Blood (2018) 132 (Supplement 1): 4109.

https://doi.org/10.1182/blood-2018-99-116750

Published: 2018

Journal Articles

Inhibition of Neutrophil Extracellular Trap Release through the Disruption of PAD4 Leads to Decreased Neutrophil and Platelet Accumulation at Sites of Venular Vascular Injury in a Murine Model of Heparin-Induced Thrombocytopenia

Kandace Gollomp, MD, Vincent Hayes, Ian Johnston, BS, Minna Kim, Guohua Zhao, Lubica Rauova, MD PhD, Mortimer Poncz, MD

Blood (2017) 130 (Supplement 1): 2268.

https://doi.org/10.1182/blood.V130.Suppl_1.2268.2268

Published: 2017

Journal Articles

Gene Expression Profiling and Cellularity of Bone Marrow CD34+/Lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia at Diagnosis Vs. 12 Months of First-Line Nilotinib Treatment

Blood (2017) 130 (Supplement 1): 4973.

https://doi.org/10.1182/blood.V130.Suppl_1.4973.4973

Published: 2017

Journal Articles

Role of Genetic Polymorphisms on Response to R-Chopregimen in Diffuse Large B-Cell Lymphoma Patients: An Interim Analysis of a Multicenter Prospective Pharmacogenetic Study

Blood (2015) 126 (23): 2483.

https://doi.org/10.1182/blood.V126.23.2483.2483

Published: 2015

Journal Articles

Serum Proteomic Analysis of Multiple Myeloma Subjects Treated with Daratumumab Monotherapy

Tineke Casneuf, Andrew Lysaght, Clare LeFave, Jaime Bald, Brendan Weiss, Niels W.C.J. van de Donk, Henk M. Lokhorst, Tahamtan Ahmadi, A. Kate Sasser

Blood (2015) 126 (23): 1837.

https://doi.org/10.1182/blood.V126.23.1837.1837

Published: 2015

Journal Articles

Pilot Study of Radiation-Targeted Donor Lymphocyte Infusion for Cancer Progression after Allogeneic Hematopoietic Stem Cell Transplantation

Nancy M. Hardy, MD, Deborah Citrin, MD, Frances T. Hakim, PhD, Daniele N. Avila, CRNP, Bazetta Blacklock-Schuver, RN, Stephanie Cotton, RN, Monica Cho, Daniel H. Fowler, MD, Juan C. Gea-Banacloche, MD, Noa G. Holtzman, MD, Karen A. Kurdziel, MD, Sarfraz Memon, MD, Steven Z. Pavletic, MD, Stefania Pittaluga, MD PhD, Jeremy J. Rose, BA, Claude Sportes, MD, Jennifer S. Wilder, RN, Ronald E. Gress, MD, Michael R. Bishop, MD

Blood (2015) 126 (23): 1962.

https://doi.org/10.1182/blood.V126.23.1962.1962

Published: 2015

Journal Articles

CD32a antibodies induce thrombocytopenia and type II hypersensitivity reactions in FCGR2A mice

Todd Meyer, Liza Robles-Carrillo, Monica Davila, Meghan Brodie, Hina Desai, Mildred Rivera-Amaya, John L. Francis, Ali Amirkhosravi

Blood (2015) 126 (19): 2230–2238.

https://doi.org/10.1182/blood-2015-04-638684

Published: 2015

Includes: Multimedia, Supplemental data

Journal Articles

Genomic Dissection of the Fcγ Receptor Region in the Context of Monoclonal Antibody Therapy

Chantal Hargreaves, PhD, Chisako Iriyama, MD PhD, Matthew JJ Rose-Zerilli, PhD, Charlotte Lee, BSc, Kathleen Potter, PhD, Rosalind Ganderton, Khiyam Hussain, Lee Machado, PhD, Edward Hollox, Sarah E Coupland, MBBS, PhD, Michael Stackpole, Melanie Oates, PhD, Andrew R. Pettitt, PhD MRCPath, Mark Cragg, PhD, Jonathan C Strefford, PhD

Blood (2014) 124 (21): 2996.

https://doi.org/10.1182/blood.V124.21.2996.2996

Published: 2014

Journal Articles

Influence of FcγRIIA H131R Polymorphism on the Risk of Thrombosis in HIT and Variable Effect of Normal IgG on Platelet Activation

Jerôme Rollin, PhD, Claire Pouplard, Dorothee Leroux, Armand Saada, Céline Behier, Valérie Gouilleux Gruart, Gilles Thibault, PharmD, Yves Gruel, MD PhD

Blood (2014) 124 (21): 234.

https://doi.org/10.1182/blood.V124.21.234.234

Published: 2014

Journal Articles

Genetic Variations In Immune Regulatory Genes and The Risk For Diffuse Large B-Cell Lymphoma

Jeong-Eun Kang, In-Suk Kim, MD, PhD, Nam-Hee Kim, Min Kyoung Kim

Blood (2013) 122 (21): 4286.

https://doi.org/10.1182/blood.V122.21.4286.4286

Published: 2013

Journal Articles

25(OH) Vitamin D 3 Affects Acute Myeloid Leukemia Cell Proliferation

Costa G Frangou, PhD, Jason Den Haese, Norma Nowak, PhD, Candace S. Johnson, PhD, Donald Trump, MD, FACP, Meir Wetzler, MD

Blood (2013) 122 (21): 5026.

https://doi.org/10.1182/blood.V122.21.5026.5026

Published: 2013

Journal Articles

Germline Genetic Variation and Risk of Follicular Lymphoma Transformation in the Modern Treatment Era

James R Cerhan, MD, PhD, Grzegorz S. Nowakowski, MD, Matthew J Maurer, MS, Bridget Charbonneau, PhD, Herve Ghesquieres, MD, PhD, Anne J. Novak, Ph.D., Yan W Asmann, PhD, Ahmet Dogan, MD, PhD, Svetomir N. Markovic, MD, PhD, Carrie A. Thompson, MD, Stephen M. Ansell, M.D., Ph.D., George J. Weiner, MD, Brian K Link, MD, Thomas M Habermann, MD, Susan L Slager, PhD

Blood (2012) 120 (21): 149.

https://doi.org/10.1182/blood.V120.21.149.149

Published: 2012

Journal Articles

Prognostic Impact of Fc Gamma-Receptor Polymorphisms and Efficacy of Rituximab in Children and Adolescents with Mature Aggressive B-NHL

Birgit Burkhardt, MD, PhD, Deniz Yavuz, Martin Zimmerman, PhD, Jutta Schieferstein, Edita Kabickova, MD, Andishe Attarbaschi, MD, Jasmin Lisfeld, MD, Bettina R. Bonn, PhD, Alfred Reiter, MD, Christine Damm-Welk, PhD

Blood (2012) 120 (21): 1547.

https://doi.org/10.1182/blood.V120.21.1547.1547

Published: 2012

Journal Articles

The Risk of Organ Specific Graft-Versus-Host Disease Can Be Predicted by the Multiple Single Nucleotide Polymorphism Based Predictive Models.

Dennis Dong Hwan Kim, MD, PhD, Hong-Hee Won, Wei Xu, Ph.D., Jieun Uhm, MD, Vikas Gupta, MD, FRCP, FRCPath, John Kuruvilla, MD, FRCPC, Hans A. Messner, MD, PhD, Jeffrey H. Lipton, MD, PhD

Blood (2012) 120 (21): 3056.

https://doi.org/10.1182/blood.V120.21.3056.3056

Published: 2012

Journal Articles

Decanucleotide Insertion Polymorphism of F7 Influences Significantly the Risk of Thrombosis in Patients with Essential Thrombocythemia

Veronika Buxhofer-Ausch, Damla Olcaydu, Bettina Gisslinger, Martin Schalling, Sophie Frantal, Juergen Thiele, Leonhard Müllauer, Hans-Michael Kvasnicka, Robert Kralovics, Heinz Gisslinger

Blood (2012) 120 (21): 1730.

https://doi.org/10.1182/blood.V120.21.1730.1730

Published: 2012

Journal Articles

β 2 -Glycoprotein 1 Antibodies Directly Activate the Platelet IgG Receptor, FcγRIIa, and Cause Thrombosis in FCGR2A Transgenic but Not in Wild Type Mice

Ali Amirkhosravi, PhD, Todd V Meyer, PhD., Liza Robles-Carrillo, MS., Meghan Hatfield, M.S., Hina Desai, M.S., Mildred Amaya, M.S., Florian Langer, MD, Steven E. McKenzie, MD, PhD, John L Francis, PhD

Blood (2012) 120 (21): 106.

https://doi.org/10.1182/blood.V120.21.106.106

Published: 2012

Journal Articles

The Diffuse Large B-Cell Lymphoma Infiltrating Macrophage Transcriptome Signature Is Enriched for Both M1 and M2 Genes and Provides an Excellent Platform for Functional Validation of Macrophage Biology in DLBCL

Rita Coutinho, MD, Aaron M. Newman, PhD, Guglielmo Rossignoli, PhD, William Day, MsC, Faridah Miraki-Moud, PhD, Tracy Chaplin, Jacek Marzec, Robert D. Petty, Sameena Iqbal, Janet Matthews, Ash A. Alizadeh, MD, PhD, John G Gribben

Blood (2012) 120 (21): 790.

https://doi.org/10.1182/blood.V120.21.790.790

Published: 2012

Journal Articles

Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms

Hervé Ghesquières, Guillaume Cartron, John Francis Seymour, Marie-Hélène Delfau-Larue, Fritz Offner, Pierre Soubeyran, Aurore Perrot, Pauline Brice, Réda Bouabdallah, Anne Sonet, Jehan Dupuis, Olivier Casasnovas, John Vincent Catalano, Alain Delmer, Fabrice Jardin, Aurélie Verney, Peggy Dartigues, Gilles Salles

Blood (2012) 120 (13): 2650–2657.

https://doi.org/10.1182/blood-2012-05-431825

Published: 2012

Journal Articles

Identification of Patient Subgroups Demonstrating Longer Progression-Free Survival (PFS) Benefit with Bortezomib-Rituximab Versus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma (FL): Biomarker Analyses of the Phase 3 LYM3001 Study

Blood (2011) 118 (21): 265.

https://doi.org/10.1182/blood.V118.21.265.265

Published: 2011

Journal Articles

The Predictive Value of FCGR3A Polymorphism on Clinical Outcomes of Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Chemotherapy

Steven I. Park, MD, Amy S. Lucas, MD, Michael Kingberg, BSc, Dominic Moore, PhD, Michael Chiu, MS, Anne M.D. Misher, BSc, Janelle Hoskins, PhD, Cherie H. Dunphy, MD, Howard L. McLeod, Pharm D, Kristy L. Richards, PhD, MD

Blood (2011) 118 (21): 89.

https://doi.org/10.1182/blood.V118.21.89.89

Published: 2011

NARROW

Prognostic Impact of Germ-Line FCGR2A (H131R), FCGR3A (F158V), and FCGR2B (I232T) Single Nucleotide Polymorphisms in Lymphoma Patients Treated with Obinutuzumab or Rituximab in Combination with Chemotherapy: Results from the Phase III GALLIUM and GOYA Clinical Trials

Inhibition of Neutrophil Extracellular Trap Release through the Disruption of PAD4 Leads to Decreased Neutrophil and Platelet Accumulation at Sites of Venular Vascular Injury in a Murine Model of Heparin-Induced Thrombocytopenia

Gene Expression Profiling and Cellularity of Bone Marrow CD34+/Lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia at Diagnosis Vs. 12 Months of First-Line Nilotinib Treatment

Role of Genetic Polymorphisms on Response to R-Chopregimen in Diffuse Large B-Cell Lymphoma Patients: An Interim Analysis of a Multicenter Prospective Pharmacogenetic Study

Serum Proteomic Analysis of Multiple Myeloma Subjects Treated with Daratumumab Monotherapy

Pilot Study of Radiation-Targeted Donor Lymphocyte Infusion for Cancer Progression after Allogeneic Hematopoietic Stem Cell Transplantation

CD32a antibodies induce thrombocytopenia and type II hypersensitivity reactions in FCGR2A mice

Genomic Dissection of the Fcγ Receptor Region in the Context of Monoclonal Antibody Therapy

Influence of FcγRIIA H131R Polymorphism on the Risk of Thrombosis in HIT and Variable Effect of Normal IgG on Platelet Activation

Genetic Variations In Immune Regulatory Genes and The Risk For Diffuse Large B-Cell Lymphoma

25(OH) Vitamin D 3 Affects Acute Myeloid Leukemia Cell Proliferation

Germline Genetic Variation and Risk of Follicular Lymphoma Transformation in the Modern Treatment Era

Prognostic Impact of Fc Gamma-Receptor Polymorphisms and Efficacy of Rituximab in Children and Adolescents with Mature Aggressive B-NHL

The Risk of Organ Specific Graft-Versus-Host Disease Can Be Predicted by the Multiple Single Nucleotide Polymorphism Based Predictive Models.

Decanucleotide Insertion Polymorphism of F7 Influences Significantly the Risk of Thrombosis in Patients with Essential Thrombocythemia

β 2 -Glycoprotein 1 Antibodies Directly Activate the Platelet IgG Receptor, FcγRIIa, and Cause Thrombosis in FCGR2A Transgenic but Not in Wild Type Mice

The Diffuse Large B-Cell Lymphoma Infiltrating Macrophage Transcriptome Signature Is Enriched for Both M1 and M2 Genes and Provides an Excellent Platform for Functional Validation of Macrophage Biology in DLBCL

Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms

Identification of Patient Subgroups Demonstrating Longer Progression-Free Survival (PFS) Benefit with Bortezomib-Rituximab Versus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma (FL): Biomarker Analyses of the Phase 3 LYM3001 Study

The Predictive Value of FCGR3A Polymorphism on Clinical Outcomes of Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only